The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFerguson Regulatory News (FERG)

Share Price Information for Ferguson (FERG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 16,385.00
Bid: 16,320.00
Ask: 16,355.00
Change: -40.00 (-0.24%)
Spread: 35.00 (0.214%)
Open: 16,275.00
High: 16,385.00
Low: 16,270.00
Prev. Close: 16,425.00
FERG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Circular and Notice of Meeting

8 Feb 2022 13:00

RNS Number : 9404A
Ferguson PLC
08 February 2022
 

 

February 8, 2022

FERGUSON PLC(the "Company")

Publication Announcement: Circular and Notice of Meeting

On January 13, 2022 Ferguson plc announced that it expected to hold a shareholder vote on or about March 10, 2022 to enable a primary US listing in line with the previously announced timeline.

Today, the Company has published a Circular and Notice of General Meeting (the "Circular") outlining further details of the proposed relocation of the Company's primary listing to the US, which will be achieved by the transfer of its listing category from a premium listing to a standard listing on the London Stock Exchange. The documents also contain the necessary shareholder resolution to be considered at the General Meeting.

A copy of the Circular is available on Ferguson's website within the Shareholder Center pages of the Investors & Media section at https://www.fergusonplc.com/en/investors-and-media/shareholder-center/agm.html and will also be submitted to the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

The Circular will be distributed to shareholders together with a form of proxy for the General Meeting which will be held on Thursday, March 10, 2022 at Freshfields Bruckhaus Deringer, 100 Bishopsgate, London, EC2P 2SR, United Kingdom. The General Meeting is currently intended to be held as a normal physical meeting. Shareholders will be notified of any changes to the General Meeting arrangements via the Company's website and an RNS announcement should this be required due to any new regulations or public health guidance relating to the COVID-19 pandemic.

Subject to the passing of the Resolution and in compliance with the notice period set out in Listing Rule 5.4A.6R(3), it is anticipated that the date of the Proposed Transfer will be May 12, 2022.

Unless stated otherwise, capitalised terms used in this announcement shall have the same meanings as in the Circular. For background information on the listing changes, please see the below "Notes to editors" section of this announcement.

 

For further information please contact

Ferguson plc

Geoff Drabble, Chairman

Tel:

+44 (0) 1189 273800

Brian Lantz, Vice President IR and Communications

Mobile:

+1 224 285 2410

Pete Kennedy, Director of Investor Relations

 

Mobile:

+1 757 603 0111

Media Enquiries

Mike Ward, Head of Corporate Communications

Mobile:

+44 (0) 7894 417060

Nina Coad, David Litterick (Brunswick)

Tel:

+44 (0) 20 7404 5959

Jonathan Doorley (Brunswick)

Tel:

+1 917 459 0419

 

 

Notes to editors

Listing changes

Ferguson's operations are now 100 per cent focused on North America and the Board continues to believe the US is the natural long-term listing location for the Company. As previously announced, after extensive shareholder consultation, the Company set out a two-step process to achieve an orderly and equitable path to achieving this aim. The first step has been achieved, with the additional US listing of ordinary shares becoming effective on the New York Stock Exchange on March 8, 2021, having been supported by over 99% of shareholders voting. In line with the timeline previously set out on the second step, Ferguson is putting forward a vote on a primary US listing on March 10, 2022. Further details are available in the Circular on the Company's website here: https://www.fergusonplc.com/en/investors-and-media/shareholder-center/agm.html.

 

About Ferguson plc

Ferguson is a $23B value-added distributor in North America providing expertise, solutions, and products from infrastructure, plumbing and appliances to HVAC, fire, fabrication and more. We make our customers' complex projects simple, successful and sustainable. Ferguson plc is listed on the London Stock Exchange (LSE: FERG) and the New York Stock Exchange (NYSE: FERG) and the company is in the FTSE 100 index of listed companies. For more information, please visit www.fergusonplc.com or follow us on LinkedIn https://www.linkedin.com/company/ferguson-enterprises.

Cautionary note regarding forward-looking statements

Certain information in this announcement is forward-looking within the meaning of the United States Private Securities Litigation Reform Act of 1995, and involves risks, assumptions and uncertainties that could cause actual results to differ materially from those expressed or implied by forward-looking statements. Forward-looking statements cover all matters which are not historical facts and speak only as of the date on which they are made. Forward-looking statements can be identified by the use of forward-looking terminology such as "anticipate," "will," "expect," "intend," or other variations or comparable terminology. Forward-looking statements include, among others, statements regarding the Company's intentions with regard to the proposed relocation of the Company's primary listing to the US, which will be achieved by the transfer of its listing category from a premium listing to a standard listing on the London Stock Exchange. Many factors could cause actual results to differ materially from those in such forward-looking statements, including, but not limited to: risks associated with our intention to relocate our primary listing to the US and any volatility in our share price and shareholder base in connection therewith; weakness in the economy, market trends, uncertainty and other conditions in the markets in which we operate, and other factors beyond our control; adverse impacts caused by the COVID-19 pandemic (or related variants) or by any current or future vaccination and/or testing mandates; unsuccessful execution of our operational strategies; and the risks set forth in our Form 20-F filed with the Securities and Exchange Commission on September 28, 2021, under the heading "Risk Factors." Forward-looking statements regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. Other than in accordance with our legal or regulatory obligations we undertake no obligation to update publicly or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOGGZGGZNNZGZZM
Date   Source Headline
8th Oct 20217:00 amRNSTransaction in Own Shares
7th Oct 20217:00 amRNSTransaction in Own Shares
6th Oct 20217:00 amRNSTransaction in Own Shares
5th Oct 20217:00 amRNSTransaction in Own Shares
4th Oct 20217:00 amRNSDirector/PDMR Shareholding
4th Oct 20217:00 amRNSTransaction in Own Shares
1st Oct 20217:00 amRNSTotal Voting Rights
1st Oct 20217:00 amRNSTransaction in Own Shares
30th Sep 20217:00 amRNSShare buy back program
29th Sep 20217:00 amRNS2021 Annual Report on Form 20-F
28th Sep 20217:00 amRNSResults for the year ended July 31, 2021
14th Sep 202110:00 amRNSNotice of Results
1st Sep 20217:00 amRNSTotal Voting Rights
24th Aug 20218:00 amRNSDirector Declaration
2nd Aug 20217:00 amRNSTotal Voting Rights
29th Jul 20217:00 amRNSTransaction in Own Shares
28th Jul 20217:00 amRNSTransaction in Own Shares
26th Jul 20217:00 amRNSTransaction in Own Shares
22nd Jul 20217:00 amRNSTransaction in Own Shares
21st Jul 20217:00 amRNSTransaction in Own Shares
20th Jul 20217:00 amRNSTransaction in Own Shares
19th Jul 20217:00 amRNSTransaction in Own Shares
16th Jul 20217:00 amRNSTransaction in Own Shares
15th Jul 20217:00 amRNSTransaction in Own Shares
14th Jul 20217:00 amRNSTransaction in Own Shares
13th Jul 20217:00 amRNSTransaction in Own Shares
9th Jul 20217:00 amRNSTransaction in Own Shares
8th Jul 20217:00 amRNSTransaction in Own Shares
7th Jul 20217:00 amRNSTransaction in Own Shares
6th Jul 20217:00 amRNSTransaction in Own Shares
5th Jul 20217:00 amRNSTransaction in Own Shares
2nd Jul 20217:00 amRNSTransaction in Own Shares
1st Jul 20217:00 amRNSTotal Voting Rights
1st Jul 20217:00 amRNSTransaction in Own Shares
30th Jun 20217:00 amRNSTransaction in Own Shares
29th Jun 20219:00 amRNSIFRS to US GAAP Investor Session
29th Jun 20217:00 amRNSTransaction in Own Shares
28th Jun 20217:00 amRNSTransaction in Own Shares
24th Jun 20217:00 amRNSTransaction in Own Shares
23rd Jun 20217:00 amRNSTransaction in Own Shares
22nd Jun 20217:00 amRNSTransaction in Own Shares
21st Jun 20217:00 amRNSTransaction in Own Shares
18th Jun 20217:00 amRNSDirector/PDMR Shareholding
18th Jun 20217:00 amRNSTransaction in Own Shares
17th Jun 20217:00 amRNSTransaction in Own Shares
16th Jun 20217:00 amRNSTransaction in Own Shares
15th Jun 20217:00 amRNSTransaction in Own Shares
14th Jun 20217:00 amRNSShare buy back program
14th Jun 20217:00 amRNSTransaction in Own Shares
11th Jun 20217:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.